|
|
|
|
|
UPDATE 1-FDA OKs Abilify for child autism irritability
- 6 Hours ago
|
|
|
|
* Approved to treat aggression, self injury, tantrums * Drug indicated as part of treatment program LOS ANGELES, Nov 20 (Reuters) - The U.S. Food and Drug Administration has approved Bristol-Myers Squibb
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Big Pharma Mergers: Good News Or Bad?
- 5 Hours ago
|
|
|
|
Whoever says you can't throw money at problems hasn't spent much time following the Big Pharma sector this year. More than $160 billion worth of buyouts involving top drugmakers has already been inked
|
|
|
|
|
|
|
|
|
|
|
|
|
Drug Companies Targeted, Again
- 11 Hours ago
|
|
|
|
David Gardner called it. Heâ??s up 1,334%! See what Davidâ??s recommending that you buy NEXT. Price gouging is unacceptable; anticipatory price gouging is 'especially offensive.' So say four House Democrats
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Most Admired Corporate Dealmakers announced
- 15 Hours ago
|
|
|
|
After a summer of compiling lists and an autumn of conducting a reader survey, we moved our second-annual Most Admired Corporate Dealmakers project across the finish line Thursday when we announced the
|
|
|
|
|
|
|
|
|
|
|
|
|
Janssen-Cilag's schizophrenia study meets primary endpoint
- 16 Hours ago
|
|
|
|
Set_Cookie( 'test', 'none', '', '/', '', '' (Get_Cookie( 'test')) else _uacct sfHover hidePopUp(which) _cfscriptLocation makeRequest(url) sendtofriend(el) (!emailCheck('emailFriendfrom', forname)) (!alphaCheck('Friendfrom',
|
|
|
|
|
|
|
|
|
|
|
|
|
Princeton Reacts to Pharma Contractions
- 19 Hours ago
|
|
|
|
PRINCETON, NJ-Throughout New Jersey, businesses are continuing to contract, leaving unprecedented amounts of office space available. Even big pharma, one of the mainstay industries of Central New Jersey,
|
|
|
|
|
|
|
|
|
|
|
|
|
Fusion IP Signs Licensing Deal With Orthopedic Firm
- 20 Hours ago
|
|
|
|
20/11/2009 00:00 LONDON -(Dow Jones)- Fusion IP PLC (FIP.LN), a company that sets up businesses based on university research, Friday said it has signed a licensing deal with a global orthopedic device
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ustekinumab (Stelaraâ�"Centocor Ortho Biotech)
- 11/19/2009
|
|
|
|
If a serious infection occurs, ustekinumab should be discontinued until the infection resolves. All patients should be evaluated for tuberculosis (TB) before initiating treatment with ustekinumab. Patients
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bayer's better Nexavar offer not NICE enough
- 11/19/2009
|
|
|
|
Britain's healthcare cost-effectiveness watchdog strikes again. The National Institute for Health and Clinical Excellence proclaimed Bayer's Nexavar too expensive for use in liver cancer patients on the
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccines become more attractive to drug developers
- 11/19/2009
|
|
|
|
Vaccines are catching up with prescription drugs as the most lucrative segment of the pharmaceutical business, as more biotech and drug firms invest in vaccine development. GlaxoSmithKline opened a vaccine-packaging
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Votes may take up to 30 minutes to influence
article rank order |
|